Great Point Partners LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Great Point Partners LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$65.07 - $98.24 $28.3 Million - $42.7 Million	-435,000 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$59.04 - $77.95 $24 Million - $31.6 Million	-405,900 Reduced 48.27%	435,000 $28.3 Million
Q2 2020 Aug 14, 2020	BUY	$29.01 - $74.23 $7.51 Million - $19.2 Million	258,995 Added 44.51%	840,900 $61.5 Million
Q1 2020 May 15, 2020	BUY	$27.51 - $57.29 $16 Million - $33.3 Million	581,905 New	581,905 $19.8 Million
Q3 2019 Nov 15, 2019	SELL	$37.38 - $49.47 $13.1 Million - $17.3 Million	-350,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$39.79 - $67.01 $13.9 Million - $23.5 Million	350,000 New	350,000 $0
Q1 2018 May 14, 2018	SELL	$22.49 - $34.56 $11.2 Million - $17.3 Million	-500,192 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$20.44 - $35.56 $10.2 Million - $17.8 Million	500,192	500,192 $13.5 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Great Point Partners LLC with notifications on news.